title: Exploratory 7-Tesla magnetic resonance spectroscopy in Huntington's disease provides in vivo evidence for impaired energy metabolism.
abstract: Huntington's disease (HD) is a neurodegenerative genetic disorder that affects the brain. Atrophy of deep grey matter structures has been reported and it is likely that underlying pathologic processes occur before, or in concurrence with, volumetric changes. Measurement of metabolite concentrations in these brain structures has the potential to provide insight into pathological processes. We aim to gain understanding of metabolite changes with respect to the disease stage and pathophysiological changes. We studied five brain regions using magnetic resonance spectroscopy (MRS) using a 7-Tesla MRI scanner. Localized proton spectra were acquired to obtain six metabolite concentrations. MRS was performed in the caudate nucleus, putamen, thalamus, hypothalamus, and frontal lobe in 44 control subjects, premanifest gene carriers and manifest HD. In the caudate nucleus, HD patients display lower NAA (p = 0.009) and lower creatine concentration (p = 0.001) as compared to controls. In the putamen, manifest HD patients show lower NAA (p = 0.024), lower creatine concentration (p = 0.027), and lower glutamate (p = 0.013). Although absolute values of NAA, creatine, and glutamate were lower, no significant differences to controls were found in the premanifest gene carriers. The lower concentrations of NAA and creatine in the caudate nucleus and putamen of early manifest HD suggest deficits in neuronal integrity and energy metabolism. The changes in glutamate could support the excitotoxicity theory. These findings not only give insight into neuropathological changes in HD but also indicate that MRS can possibly be applied in future clinical trails to evaluate medication targeted at specific metabolic processes.
authors: Department of Neurology, Leiden University Medical Center, Albinusdreef 2, 2300 RC, Leiden, The Netherlands. s.j.a.van_den_bogaard@lumc.nl
authors: Simon J A
authors: SJ
authors: van den Bogaard
authors: Eve M
authors: EM
authors: Dumas
authors: Wouter M
authors: WM
authors: Teeuwisse
authors: Hermien E
authors: HE
authors: Kan
authors: Andrew
authors: A
authors: Webb
authors: Raymund A C
authors: RA
authors: Roos
authors: Jeroen
authors: J
authors: van der Grond
references: Neurology. 2007 Mar 20;68(12):906-10
references: 17372125
references: Ann Neurol. 1997 May;41(5):689-92
references: 9153534
references: Parkinsonism Relat Disord. 1998 Oct;4(3):123-7
references: 18591101
references: Neurology. 1993 Dec;43(12):2689-95
references: 8255479
references: Lancet. 1994 May 7;343(8906):1170
references: 7910266
references: Neurology. 2010 Nov 9;75(19):1702-10
references: 21060093
references: Tijdschr Gerontol Geriatr. 1991 Feb;22(1):15-9
references: 1877068
references: Brain. 2008 Nov;131(Pt 11):2860-9
references: 18829696
references: J Neuroophthalmol. 2005 Sep;25(3):217-26
references: 16148633
references: Brain Res Rev. 2008 Jun;58(1):209-25
references: 18486229
references: Brain Res. 2007 Sep 7;1168:67-71
references: 17707354
references: Brain Res. 2005 Jan 7;1031(1):82-9
references: 15621015
references: Brain Res. 1992 May 15;580(1-2):44-8
references: 1387037
references: Clin Genet. 2004 Apr;65(4):267-77
references: 15025718
references: Mov Disord. 1996 Mar;11(2):167-73
references: 8684387
references: Neurology. 2003 Jul 8;61(1):141-2
references: 12847181
references: NMR Biomed. 2001 Jun;14(4):260-4
references: 11410943
references: J Neurol. 2011 Mar;258(3):412-20
references: 20936300
references: Arch Med Res. 2008 Apr;39(3):265-76
references: 18279698
references: Neurology. 2004 Jul 13;63(1):66-72
references: 15249612
references: Curr Opin Neurol. 2008 Aug;21(4):497-503
references: 18607213
references: Magn Reson Med. 2009 Jun;61(6):1279-85
references: 19319893
references: BMJ. 1998 Apr 18;316(7139):1236-8
references: 9553006
references: Neurology. 1999 Sep 11;53(4):806-12
references: 10489045
references: Neurology. 1998 May;50(5):1357-65
references: 9595987
references: Lancet Neurol. 2009 Sep;8(9):791-801
references: 19646924
references: Magn Reson Med. 1993 Dec;30(6):672-9
references: 8139448
references: Magn Reson Med. 2009 Oct;62(4):868-79
references: 19591201
references: J Clin Endocrinol Metab. 2009 Apr;94(4):1223-8
references: 19174491
references: J Neurol Neurosurg Psychiatry. 2008 Aug;79(8):874-80
references: 18096682
references: Mov Disord. 2007 Oct 31;22(14):2052-6
references: 17702030
references: Neurology. 1998 Jan;50(1):252-8
references: 9443488